Why the study?
Progressive tricuspid regurgitation is linked to worse outcomes, driving the clinical need for more accurate assessment of morphology and severity to guide emerging percutaneous, surgical, and medical therapies.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Accurate TR assessment may refine selection for percutaneous therapies; leaves optimal quantification methods open for validation.
Current understanding that progressive tricuspid regurgitation (TR) is associated with worse outcomes has highlighted the clinical need for a more accurate assessment of TR morphology and severity. This need has been further emphasized owing to the development of a myriad of percutaneous right-sided interventions, which may offer successful treatment of TR in selected patients. Understanding the etiology and quantification of the severity of TR has important implications in the selection of novel therapeutic strategies, i.e., medical vs. percutaneous vs. surgical approaches. Newer grading schemas that better reflect the TR lesion severity have been recently proposed and may facilitate monitoring of the evolution of TR following percutaneous and/or surgical treatment. In this review, we summarize contemporary concepts regarding tricuspid valve morphology, TR etiology, and associated mechanisms and echocardiographic approaches to grade TR severity.
No takes yet. Share an insight, caveat, or question.
Singulane et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: